GHK-Cu exists in several delivery forms developed for topical application, and the differences between them affect how the compound reaches the dermis rather than staying on the skin surface. ghk cu formulations vary in carrier system, concentration, and delivery mechanism, with each format developed to address specific limitations of direct peptide application to intact skin. Peptides in their free form have limited skin penetration on their own, and carrier development in this area has focused on moving the compound through the epidermis to where fibroblast and matrix targets are located.
Liposomal encapsulation is one established format. Liposomes are phospholipid vesicles that carry peptide cargo through the stratum corneum more effectively than aqueous solution alone. GHK-Cu encapsulated in liposomes shows higher dermal penetration in permeation studies than unencapsulated forms at comparable concentrations, and the lipid carrier is biocompatible with skin membrane structures, which reduces surface reactivity concerns.
Nanoparticle delivery systems
Nanoparticle carriers represent a more recent development in GHK-Cu topical delivery research. Polymer-based nanoparticles and solid lipid nanoparticles have both been investigated as carriers for this compound. Nanoparticle systems can be engineered to release their peptide cargo at controlled rates after penetrating the epidermis, which extends the duration of compound availability in the dermis compared to formulations that release the full dose at application.
Chitosan nanoparticles have attracted specific research interest as a GHK-Cu carrier. Chitosan is positively charged, which improves adhesion to the negatively charged skin surface and supports penetration into the epidermis. Studies comparing chitosan-encapsulated GHK-Cu against free compound delivery have recorded higher dermal collagen output in treated tissue using the encapsulated format at the same nominal concentration.
Hydrogel formats
- Aqueous hydrogels – Water-based hydrogel matrices suspend copper peptide GHK-Cu in a format that maintains skin surface contact over extended periods. Hydrogels support hydration of the stratum corneum during application, which temporarily increases permeability and can improve peptide passage into the epidermis. Carbomer and hyaluronic acid-based hydrogels are among the carrier matrices used in GHK-Cu topical research.
- Crosslinked polymer gels – Crosslinked hydrogel systems provide slower compound release than simple aqueous gels. The crosslinked polymer network releases GHK-Cu gradually as the gel contacts skin moisture, which reduces the peak concentration at the surface and spreads delivery over a longer contact window. This format has been studied in contexts where sustained release is more relevant to the target tissue than rapid high-concentration delivery.
Serum and emulsion formats
- Serum formulations carry GHK-Cu in low-viscosity aqueous bases with penetration enhancers including propylene glycol, ethoxydiglycol, and fatty acid derivatives. These enhance compounds temporarily disrupt stratum corneum lipid organisation, creating pathways for peptide movement into the epidermis. Concentration in serum formats varies across research preparations, with higher concentrations not linearly correlated with higher dermal delivery in all studies.
- Emulsion-based formats suspend GHK-Cu across oil and water phases. Oil-in-water emulsions place the compound in the aqueous phase for surface delivery, while water-in-oil formats can increase contact time and reduce surface evaporation. The emulsion droplet size affects how the compound distributes across skin topography during application, with smaller droplet sizes producing more even surface coverage at the same applied volume.
GHK-Cu topical formats each address skin penetration through different mechanisms. Liposomal, nanoparticle, hydrogel, serum, and emulsion systems have all been studied in research contexts, with delivery depth and release rate varying between them depending on carrier design.
